The Delhi High Court has issued an interim injunction restraining Zydus from launching its Nivolumab biosimilar, siding with Squibb’s claim of imminent patent infringement.
Read more about Squibb Secures Interim Injunction Against Zydus in Nivolumab Patent Dispute